PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $166,056 | -37.8% | 14,800 | -38.6% | 0.00% | -100.0% |
Q3 2022 | $267,000 | -4.0% | 24,100 | -26.7% | 0.00% | 0.0% |
Q2 2022 | $278,000 | -46.2% | 32,900 | -13.4% | 0.00% | 0.0% |
Q1 2022 | $517,000 | -18.1% | 38,000 | +18.4% | 0.00% | -50.0% |
Q4 2021 | $631,000 | +20.0% | 32,100 | +95.7% | 0.00% | +100.0% |
Q3 2021 | $526,000 | -39.0% | 16,400 | -35.7% | 0.00% | -50.0% |
Q2 2021 | $863,000 | -26.8% | 25,500 | -18.8% | 0.00% | -33.3% |
Q1 2021 | $1,179,000 | – | 31,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |